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poor and confusing. Data from the author's
centre is interspersed with that from the
literature; the latter receiving sparse con-
sideration, omitting important details of the
varying techniques. There is no discussion of
the merits of the widely differing treatment
volumes which are used in the treatment of
bladder cancer. The final discussion in this
chapter relates only to super-fraction X-ray
therapy fot which little evidence is advanced
that it is indeed superior. This section
is concluded with a chapter on the neglected
aspect of the prectical difficulties for a
patient with an ileal conduit. Consideration is
then given to the efficacy of chemotherapy in
advanced cancer. Numerous agents and
combinations are described, and a liberal
amount of data is presented. However, the
end results are as yet disappointing, and
more effective agents or combinations are
sorely needed. Future trials of the combi-
nation of chemotherapy with either radio-
therapy or surgery are outlined. The results
are awaited with interest.
There is a section on immunotherapy, per-
haps inappropriately long considering it's
lack of current use in bladder cancer.
Finally there is a concise overview and a
comprehensive index.
Overall it is a well presented and useful
volume on the dilemmas of one aspect of
current oncological practice.
G. READ
The Interaction of Cancer and Host: Its
Therapeutic Significance. M. F. A.
WOODRUFF. (1981) London: Academic
Press. 467 pp. £26.20 net.
The role of the host in the growth and
disseonination of malignant tumours involves
more than supplying the neoplastic cells with
oxygen and nutrition. The statement that
tumours are autonomous new growths of
tissue, independent of any of the factors that
control the growth and equilibrium ofnormal
tissues, does not apply to many experimental
situations, and is clearly untenable for most
human tumours, where phenomena such as
sudden re-appearance after long latency pro-
vide tantalizing clues to the existence of con-
trol processes. In the field ofhost-tumour in-
teraction the clinicians have the leads for
tumour biologists to follow. Professor
Woodruff is one of the rare individuals who
has a deep understanding and appreciation of
the clinical as well as the experimental field,
to both of which he has made signal contri-
butions. He is, therefore, the ideal individual
to write a book on the interaction of cancer
and host, which he aptly describes as antago-
nistic symbiosis. The monograph he has
produced is authoritative, sober but yet
stimulating; it is a scholarly work with a
mammoth bibliography that makes it an
invaluable work of reference.
The host functions necessary for tumour
growth are various; the most essential (in
the case of solid tumours) is, of course, to
provide blood vessels, there are many in-
stances where a supply of hormones is
needed, and the concept of cross-feeding by
stromal cells is gaining support. Restraint
over tumour development can be exerted by
the haemostatic processes of the host,
especially in metastatic spread. However,
the area which has attracted most attention
involves control by immune mechanisms
which can be divided into two broad cate-
gories: those which have to be induced by a
specific antigen and require T cells, and those
which Woodruff refers to as "para-immuno-
logical", which are innate and selective, but
not specific. Though this monograph ad-
dresses itself to all aspects of interaction be-
tween cancer and the host, in both experi-
mental animals and man, the immunological
aspects are the centre-piece. In part, no
doubt, the emphasis on immunity derives
from the author's own involvement in this
field, but mostly it is because this is the
area of host-tumour interaction in which
research has been most active in the last 20
years.
The short opening chapter, entitled
"Methods", addresses itself to the com-
plexities of studies in man and to the diffi-
culties of the choice of worthwhile experi-
mental models. This is followed by a thought-
ful and critical review on carcinogenesis, in
which the section on interference with the
carcinogenic process by homeostatic and
immunopotentiating mechanisms should be
studied by those who emphasize the poten-
tialities of chemo-prevention-the "in" topic
of the 80s! The next two chapters deal with
relevant aspects of the biology of neoplasia,
stressing that metastasis is the core problem
of cancer. He draws attention to evidence
for the multi-focal origin of some cancers and
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larger areas of tissue. Tumour immunology
is covered in depth, and almost half the
book is devoted to immunotherapy. The
description of the experimental basis for this
therapy is logical, critical and provides the
best and most balanced overview of this
subject that I have read. The trials and tribu-
lations of the more recent attempts at im-
miunotherapy of human cancer are precisely
reported in the last chapter. This cannot be
faulted as a review but I was disappointed by
the last section "Present position and future
prospects," which is vague and indecisive.
Sadly, I suppose this reflects the state of the
subject, for if the facts permitted a grand
synthesis, surely Professor Woodruff would
be the man to make it.
P. ALEXANDER
Transplantation Today Volume 6. A. P.
MONACO, M. L. WOOD & F. T. RAPAPORT.
(1981) New York: Grune and Stratton.
1305 pp. $37.50 net.
The main impediment to successful tissue
transplantation is immunological rejection. In
the case of marrow transplants it is the
recipient who may elicit an immune response
in the marrow cells of the donor, leading to
graft-versus-host disease. The main objec-
tives of current transplantation research are
to avoid inducing rejection, either by care-
fully matching donor and recipient HLA
antigens, orbythe use ofimmuno-suppressive
drugs. "Transplantation Today" Volume 6
is a collection of papers delivered at the
Eighth International Congress of the Trans-
plantation Society, held in Boston, U.S.A. in
1980, concerned largely with the conceptual
and practical problems presented by re-
jection. Because histocompatibility research
is continuously defining more tissue antigens
however, it may never be possible to achieve
the goal of donor-recipient matching. Some
workers, believe that this may not be
necessary, since few antigens may be crucial
in triggering rejection. This explains the
relatively large number of contributions re-
lating to the HLA-D/DR antigen system.
To the clinician charged with coping with the
daily problem of rejection, it is often necess-
ary to use more drastic means to modify
immunity, achieved by a selection of gener-
ally highly effective immuno-suppressive
drugs. However, the long-term use of these
drugs has its penalities. One of these is the
higher incidence of malignant disease in
transplant recipients than in normal indi-
viduals. Penn suggests that the incidence of
non-Hodgkin's lymphoma is 45-100-fold
higher than in the general population.
Clearly, these alarming figures have to be
set against the potential benefits which
accrue from transplantation. It is a subject
that might have warranted more space in this
volume. The diversity of histocompatibility
research generated by finding that the genes
coding for transplantation antigens are in-
volved in, or associated with the control of
immunity has created something of a
dilemma that clearly emerges in this volume.
In attempting to present the current
status of transplantation research is it neces-
sary to cover the much wider field ofImmuno-
biology? In addition, many papers are not
presenting new results, though they are
short enough in most cases for this not to
matter too much. But the weight of numbers
obscures more fundamental contributions.
There is a good argument for reducing many
of the papers to abstract lengths.
G. M. TAYLOR
Hodgkin's Disease and the Lymphomas
Vol. 4. Ed. C. R. TAYLOR. (1981) Edin-
burgh: Churchill Livingstone. 377 pp.
£24.00 net.
This is the 4th Annual Review ofHodgkin's
disease and Lymphomas by Clive Taylor, and
as usual with his reviews, they are a pleasure
to read, with perhaps more attention than
might have been expected to making the
English intelligible and enjoyable.
It is perhaps inevitable that this review
should concentrate mainly on non-Hodgkin's
lymphoma, and in particular, on the con-
siderable turmoil in the histological classifi-
cation of non-Hodgkin's lymphoma which
exists at the moment. In this respect, the
book fulfils an important and timely role in
summarizing and gathering together the
wealth of information which has recently
been published about the pathological and
immunological classification of lymphomas.
Dr Taylor and his co-authors wisely do not
come to any definite conclusions on which
classification is superior, though, because the
book has been written and compiled in
California at Professor Luke's centre, con-